Tag Archives: celg

Celgene, Actavis Among 4 Top-Rated Big-Cap Drugmakers

Drugmakers Celgene (CELG) and Biogen Idec (BIIB) are among four big-cap drugmakers with deep pockets and proven product lines and processes. Today’s Screen Of The Day is Big Cap Leaders, top-rated large-cap stocks priced above 15. The four drugmakers on the Big Cap Leaders list include biotechs Celgene and Biogen Idec as well as generic drugmakers Actavis (ACT) and Perrigo (PRGO). Celgene and Actavis are also on the proprietary IBD Leaderboard

OncoMed, Celgene Strike Cancer Drug Development Deal

Biotech OncoMed (OMED) announced Tuesday that it’s collaborating with Celgene (CELG) to jointly develop and market its anti-cancer stem cell products, sending OncoMed stock up 75% in the stock market today. Celgene agreed to pay OncoMed $155 million up front, with further payments contingent on the products meeting certain clinical, regulatory and commercial milestones. OncoMed said payments for its most developed candidate, demcizumab, could

Pharmacyclics Drug Wins One Approval, Awaits Another

The Food and Drug Administration approved Pharmacyclics’ (PCYC) cancer drug ibrutinib Wednesday, but it only cleared one of the two diseases the company had applied to treat. The FDA approved the drug, now renamed Imbruvica, to treat mantle-cell lymphoma, a rare form of lymphoma currently treated with Celgene’s (CELG) Revlimid and Takeda’s Velcade. It’s only the second product to be approved under the agency’s new “breakthrough therapy”